During the past decade, Klinik und Poliklinik für Dermatologie und Allergologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinik und Poliklinik für Dermatologie und Allergologie" are "Advanced BRAFV600 Wild-type Melanoma" (1 trials), "Basal Cell Nevus Syndrome" (1 trials), "Melanoma" (1 trials) and "Uveal Melanoma" (1 trials). Many other conditions were trialed in "Klinik und Poliklinik für Dermatologie und Allergologie" in a lesser frequency.

Most popular intervention types in "Klinik und Poliklinik für Dermatologie und Allergologie" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Cobimetinib" (2 trials), "Pembrolizumab" (2 trials), "Atezolizumab Placebo" (1 trials) and "Dacarbazine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinik und Poliklinik für Dermatologie und Allergologie" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Klinik und Poliklinik für Dermatologie und Allergologie". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Klinik und Poliklinik für Dermatologie und Allergologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinik und Poliklinik für Dermatologie und Allergologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".